Table 2: Proportion of patients with diabetes in the United States and England whose electronic medical records indicated achievement of selected quality-of-care indicators within the 15 months before the last visit on record
Quality-of-care indicator% of patients*
United StatesEngland†
n = NA
n = 622 260
Coded diagnosis only
n = 56 492
Medication use only
n = 228 926
Coded diagnosis and medication use
n = 336 842
Record of BMI57.354.249.263.494.7
Record of HbA1c59.249.840.473.597.2
Last HbA1c ≤ 7%33.845.923.838.653.8
Last HbA1c ≤ 8%46.448.832.455.577.4
Last HbA1c ≤ 9%52.349.336.163.788.0
Record of the presence or absence of peripheral pulsesNRNRNRNR91.1
Record of neuropathy testingNRNRNRNR90.8
Record of retinal screeningNRNRNRNR90.9
Record of blood pressure88.086.781.592.798.3
Last blood pressure ≤ 145/85 mm Hg67.666.962.171.480.6
Record of microalbuminuria testing (among patients without proteinuria)33.424.521.443.088.5
Record of treatment with ACE inhibitor or angiotensin-receptor blocker (among patients with proteinuria‡ or microalbuminuria)85.757.195.085.880.0
Record of estimated glomerular filtration rate or serum creatinine testing69.370.054.179.697.0
Record of total cholesterol59.761.543.570.496.0
Last total cholesterol level ≤ 5 mmol/L44.641.633.053.083.0
Influenza vaccination in the preceding period Sept. 1 to Mar. 31NRNRNRNR90.4

Note: ACE = angiotensin-converting enzyme, BMI = body mass index, HbA1c = glycated hemoglobin, NA = not available, NR = not recorded.
*Between-column comparisons are all significant at p < 0.01.
†All patients with diagnostic code for diabetes 
‡Proteinuria defined as albumin (or protein) > 150 mg in a 24-hour collection or > 20 mg/dL protein or > 23 mg albumin in a urine sample.